Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27


Ivabradine in stable coronary artery disease without clinical heart failure.

Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R; SIGNIFY Investigators.

N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31.


2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H.

Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29. No abstract available.


Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators.

Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3.


Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.

Maggioni AP, Anker SD, Dahlström U, Filippatos G, Ponikowski P, Zannad F, Amir O, Chioncel O, Leiro MC, Drozdz J, Erglis A, Fazlibegovic E, Fonseca C, Fruhwald F, Gatzov P, Goncalvesova E, Hassanein M, Hradec J, Kavoliuniene A, Lainscak M, Logeart D, Merkely B, Metra M, Persson H, Seferovic P, Temizhan A, Tousoulis D, Tavazzi L; Heart Failure Association of the ESC.

Eur J Heart Fail. 2013 Oct;15(10):1173-84. doi: 10.1093/eurjhf/hft134. Epub 2013 Aug 26.


Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups.

Seferovic PM, Stoerk S, Filippatos G, Mareev V, Kavoliuniene A, Ristic AD, Ponikowski P, McMurray J, Maggioni A, Ruschitzka F, van Veldhuisen DJ, Coats A, Piepoli M, McDonagh T, Riley J, Hoes A, Pieske B, Dobric M, Papp Z, Mebazaa A, Parissis J, Ben Gal T, Vinereanu D, Brito D, Altenberger J, Gatzov P, Milinkovic I, Hradec J, Trochu JN, Amir O, Moura B, Lainscak M, Comin J, Wikström G, Anker S; Committee of National Heart Failure Societies or Working Groups of the Heart Failure Association of the European Society of Cardiology.

Eur J Heart Fail. 2013 Sep;15(9):947-59. doi: 10.1093/eurjhf/hft092. Epub 2013 Jun 19.


Determinants of reduced tricuspid annular plane systolic excursion in patients with severe systolic left ventricular dysfunction.

Ereminiene E, Vaskelyte JJ, Stoskute N, Kavoliuniene A, Bieseviciene M, Ordiene R, Nedzelskiene I.

Acta Cardiol. 2012 Dec;67(6):657-63.


Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist's point of view.

Kavoliuniene A, Vaitiekiene A, Cesnaite G.

Int J Cardiol. 2013 Jul 1;166(3):554-8. doi: 10.1016/j.ijcard.2012.05.003. Epub 2012 May 30. Review.


Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W; ROCKET AF Steering Committee Investigators.

Lancet Neurol. 2012 Apr;11(4):315-22. doi: 10.1016/S1474-4422(12)70042-X. Epub 2012 Mar 7.


Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators.

N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.


Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].


Characteristics and management of acute heart failure patients in a single university hospital center.

Venskutonyte L, Molyte I, Ablonskyte-Dūdoniene R, Mizariene V, Kavoliūniene A.

Medicina (Kaunas). 2009;45(11):855-70.


The value of 99mTc-MIBI myocardial perfusion imaging in differentiation of heart failure conditioned by global left ventricular systolic impairment.

Ragaisyte N, Kavoliūniene A, Vaicekavicius E, Navickas R, Kulakiene I, Vencloviene J, Laukaitiene J, Janenaite J, Janavicius A.

Medicina (Kaunas). 2009;45(4):262-8.


Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy.

Sinkiewicz W, Glazer RD, Kavoliuniene A, Miglinas M, Prak H, Wernsing M, Yen J.

Curr Med Res Opin. 2009 Feb;25(2):315-24. doi: 10.1185/03007990802630588 .


[Impact of a long-term complex rehabilitation on chronic fatigue and cardiorespiratory parameters in patients with chronic heart failure].

Vasiliauskas D, Kavoliūniene A, Jasiukeviciene L, Grizas V, Statkeviciene A, Leimoniene L, Tumyniene V, Kubilius R.

Medicina (Kaunas). 2008;44(12):911-21. Lithuanian.


[Evaluation of a chronic fatigue in patients with moderate-to-severe chronic heart failure].

Jasiukeviciene L, Vasiliauskas D, Kavoliūniene A, Marcinkeviciene J, Grybauskiene R, Grizas V, Tumyniene V.

Medicina (Kaunas). 2008;44(5):366-72. Lithuanian.


[Ischemic cardiomyopathy: possibilities of surgical treatment].

Benetis R, Simukauskiene A, Jankauskiene L, Kavoliūniene A.

Medicina (Kaunas). 2007;43(11):909-17. Review. Lithuanian.


Effects of beta blockers on left ventricular diastolic function: the importance of optimal heart rate reduction.

Jurkevicius R, Sakalyte G, Kavoliŭniene A.

Acta Cardiol. 2007 Jun;62(3):269-74.


[Left ventricular remodeling in ischemic heart disease patients with signs and symptoms of chronic heart failure: an impact of the long-term exercise training].

Vasiliauskas D, Kavoliūniene A, Jasiukeviciene L, Grizas V, Marcinkeviciene J, Raugaliene R, Leimoniene L, Tumyniene V.

Medicina (Kaunas). 2006;42(12):965-74. Lithuanian.


[The main aspects of symptomatic therapy of chronic heart failure].

Zaliaduonyte-Peksiene D, Mikuckaite L, Kavoliūniene A.

Medicina (Kaunas). 2006;42(11):949-55. Review. Lithuanian.


[Successful treatment of degenerative critical aortic stenosis at stage of valvular cardiomyopathy].

Kavoliūniene A, Jonkaitiene R, Benetis R, Kozlovaite V.

Medicina (Kaunas). 2006;42(6):492-8. Lithuanian.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk